Common questions about Aidra (FAQ)
Q: What is the main reason doctors prescribe Aidra?
A: Aidra is officially prescribed for the long-term management of active Rheumatoid Arthritis (RA) and active Psoriatic Arthritis (PsA). It is intended for use in adults to help reduce the signs and symptoms of these chronic inflammatory conditions.
Q: How quickly does Aidra start working after the first time taking it?
A: Studies and official product information indicate that the therapeutic effect of Aidra is generally gradual. The active substance has a long half-life, meaning it takes time—approximately 20 weeks—for the drug to reach a steady level in the body where it can exert its full effect.
Q: What happens if I stop taking Aidra suddenly?
A: If treatment with Aidra is discontinued, the active substance can remain in the system for up to two years without intervention. Official regulatory documents note that an accelerated drug elimination procedure—such as utilizing specific medications like cholestyramine or activated charcoal—is typically utilized to rapidly clear the substance from the body.
Q: Can Aidra cause long-term health issues?
A: Regulatory documents include a Boxed Warning that highlights the risks of certain serious complications. These include the potential for severe liver injury, which can be fatal, and rare but serious risks like severe infections and a lung condition called interstitial lung disease. Monitoring tests are typically implemented by the healthcare provider.
Q: Does Aidra have a 'black box warning' from the FDA?
A: Yes, the official product labeling from the FDA includes a Boxed Warning—sometimes referred to as a 'black box warning.' This warning highlights two critical safety concerns: the risk of Embryo-Fetal Toxicity (harm to an unborn baby) and the risk of Severe Liver Injury.
Q: Is it possible for Aidra to cause weight gain or weight loss?
A: Official reports and post-market data indicate that weight loss has been associated with the use of the active ingredient in Aidra. This is a potential effect that has been reported by patients during clinical studies.
Q: What are the ingredients in Aidra besides the main active component?
A: The active substance in Aidra is leflunomide. Official documentation lists various inactive ingredients (excipients) necessary to form the tablet, which may include components such as magnesium stearate, lactose monohydrate, titanium dioxide, and povidone.
Q: What kind of monitoring or tests are required while taking Aidra?
A: Due to the potential for serious adverse reactions, regulatory guidance requires ongoing laboratory tests. These include checks for serum alanine aminotransferase (ALT) to monitor liver function and checks of blood cell counts (such as white blood cells and platelets). Blood pressure should also be routinely checked.
Q: How long does Aidra stay in your system after the last dose?
A: The active substance in Aidra has a very long duration in the body, with a typical half-life of about two weeks. Without an accelerated elimination procedure to actively remove the drug, it can take up to two years for the active metabolite to clear and reach undetectable levels in the plasma.
Q: Is Aidra considered a new or established medication?
A: Aidra is considered an established medication in its class. Its active ingredient, leflunomide, received initial approval from the FDA in 1998 as a Disease-Modifying Antirheumatic Drug (DMARD).
Q: What happens if I forget a dose of Aidra?
A: Official guidance describes the approach for a missed dose as taking it as soon as possible, or skipping it if it is almost time for the next dose. Official guidance describes that a double dose should not be taken to make up for a single missed dose.
Q: Is it normal to feel a change in mood while on Aidra?
A: While the full range of side effects is complex, official product information indicates that patients should be monitored for any unusual mental or mood changes. These changes may be considered a potentially serious side effect.
Q: Can Aidra be taken with over-the-counter pain relievers like ibuprofen?
A: Information on drug interactions suggests that combining Aidra with NSAIDs, such as ibuprofen, may increase the risk of liver damage. This potential interaction may lead to the need for dosage adjustment or increased monitoring by a healthcare provider.
Q: Does Aidra have any documented interaction with alcohol?
A: Yes, official regulatory labels indicate that alcohol use should be avoided while taking Aidra. This precaution is due to the increased risk of hepatotoxicity (liver damage), as both alcohol and Aidra can affect the liver.
Q: What should I do if I suspect an allergic reaction to Aidra?
A: Serious symptoms like an allergic response require immediate medical evaluation. Symptoms that warrant immediate care include difficulty breathing, the development of hives, or swelling of the face, mouth, or throat.
Q: Why is Aidra sometimes referred to by a different name?
A: Aidra is a specific brand name for the generic active substance leflunomide. Because of this, the medicine may be referred to by its generic name or by other brand names under which it is marketed internationally, such as Arava.
Q: Is it true that Aidra can affect vision?
A: Official safety data lists vision changes as a symptom that may be associated with more serious side effects. If a patient experiences vision changes while taking Aidra, it is a symptom that may require immediate medical evaluation.
